Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies-Reference-Cited by-同舟云学术

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies

Published:2022-10-09 Issue:1 Volume:11 Page:2412-2422
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Huang Qingrui¹,Han Xiaonan¹,Yan Jinghua¹²^ORCID

Affiliation:

1. CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, People’s Republic of China

2. University of Chinese Academy of Sciences, Beijing, People’s Republic of China

Funder

National Key Research and Development Project

National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2125348

Reference90 articles.

1. COVID-19 vaccination: The road ahead

2. Viral targets for vaccines against COVID-19

3. A single-dose mRNA vaccine provides a long-term protection for hACE2 transgenic mice from SARS-CoV-2

4. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

5. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Structure and inhibition of SARS-CoV-2 spike refolding in membranes;Science;2024-08-16

2. Enhanced Assessment of Cross-Reactive Antigenic Determinants within the Spike Protein;International Journal of Molecular Sciences;2024-07-26

3. Antibody drugs targeting SARS-CoV-2: Time for a rethink?;Biomedicine & Pharmacotherapy;2024-07

4. Exploring the ability of the MD+FoldX method to predict SARS-CoV-2 antibody escape mutations using large-scale data;2024-05-22

5. Natural Antibodies Produced in Vaccinated Patients and COVID-19 Convalescents Hydrolyze Recombinant RBD and Nucleocapsid (N) Proteins;Biomedicines;2024-05-02